AUTL
Price
$2.35
Change
+$0.09 (+3.98%)
Updated
Jun 6, 12:13 PM (EDT)
Capitalization
601.47M
55 days until earnings call
ELEV
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Jun 5 closing price
Capitalization
17.84M
61 days until earnings call
Interact to see
Advertisement

AUTL vs ELEV

Header iconAUTL vs ELEV Comparison
Open Charts AUTL vs ELEVBanner chart's image
Autolus Therapeutics
Price$2.35
Change+$0.09 (+3.98%)
Volume$5.4K
Capitalization601.47M
Elevation Oncology
Price$0.31
Change+$0.01 (+3.33%)
Volume$292.66K
Capitalization17.84M
AUTL vs ELEV Comparison Chart
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. ELEV commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a StrongBuy and ELEV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (AUTL: $2.26 vs. ELEV: $0.30)
Brand notoriety: AUTL and ELEV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 135% vs. ELEV: 31%
Market capitalization -- AUTL: $601.47M vs. ELEV: $17.84M
AUTL [@Biotechnology] is valued at $601.47M. ELEV’s [@Biotechnology] market capitalization is $17.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 0 FA rating(s) are green whileELEV’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 0 green, 5 red.
  • ELEV’s FA Score: 1 green, 4 red.
According to our system of comparison, AUTL is a better buy in the long-term than ELEV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 6 TA indicator(s) are bullish while ELEV’s TA Score has 2 bullish TA indicator(s).

  • AUTL’s TA Score: 6 bullish, 4 bearish.
  • ELEV’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, AUTL is a better buy in the short-term than ELEV.

Price Growth

AUTL (@Biotechnology) experienced а +29.14% price change this week, while ELEV (@Biotechnology) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

AUTL is expected to report earnings on Jul 31, 2025.

ELEV is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($601M) has a higher market cap than ELEV($17.8M). AUTL YTD gains are higher at: -3.830 vs. ELEV (-46.463). ELEV has higher annual earnings (EBITDA): -40.42M vs. AUTL (-226.02M). AUTL has more cash in the bank: 517M vs. ELEV (93.2M). ELEV has less debt than AUTL: ELEV (31.1M) vs AUTL (57.7M). AUTL has higher revenues than ELEV: AUTL (9.01M) vs ELEV (0).
AUTLELEVAUTL / ELEV
Capitalization601M17.8M3,376%
EBITDA-226.02M-40.42M559%
Gain YTD-3.830-46.4638%
P/E RatioN/AN/A-
Revenue9.01M0-
Total Cash517M93.2M555%
Total Debt57.7M31.1M186%
FUNDAMENTALS RATINGS
AUTL: Fundamental Ratings
AUTL
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUTLELEV
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 24 days ago
88%
Bearish Trend 1 day ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
85%
Aroon
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WXCRX13.700.11
+0.81%
William Blair Emerg Mkts ex China Gr R6
NIECX17.87N/A
N/A
BNY Mellon International Equity C
DWGCX11.77N/A
N/A
American Funds Dvlpg Wld Gr&Inc C
JVAPX36.48N/A
N/A
JPMorgan Value Advantage R3
WAMCX30.74-0.02
-0.07%
Wasatch Ultra Growth

ELEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELEV has been loosely correlated with TBPH. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELEV jumps, then TBPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
-0.99%
TBPH - ELEV
39%
Loosely correlated
-2.09%
BOLT - ELEV
31%
Poorly correlated
-7.97%
ADAP - ELEV
30%
Poorly correlated
+0.25%
AUTL - ELEV
29%
Poorly correlated
+8.13%
AKBA - ELEV
29%
Poorly correlated
+1.65%
More